Literature DB >> 11907042

Biosynthesis of surfactant protein C (SP-C). Sorting of SP-C proprotein involves homomeric association via a signal anchor domain.

Wen-Jing Wang1, Scott J Russo, Surafel Mulugeta, Michael F Beers.   

Abstract

Rat surfactant protein C (SP-C) is synthesized as a 194-amino acid propeptide (SP-C-(1-194)) that is directed to the distal secretory pathway and proteolytically processed as an integral membrane protein to yield its mature form. We had shown previously that trafficking of proSP-C is mediated both by a signal anchor domain contained within the mature SP-C sequence and by a targeting domain in the NH(2)-flanking propeptide. Based on evidence from other integral membrane proteins, we hypothesized that proSP-C targeting is effected by oligomerization of proSP-C monomers. To evaluate this in vitro, cDNA constructs encoding for either wild type proSP-C (pcDNA3/SP-C-(1-194)) or heterologous fusion proteins containing green fluorescent protein (EGFP) linked to SP-C-(1-194) (EGFP/SP-C-(1-194)), to mutant proSP-C lacking the NH(2) targeting domain (EGFP/SP-C-(24-194)), or to mature SP-C alone (EGFP/SP-C-(24-58)) were produced. In transfected A549 cells, fluorescence microscopy revealed that pcDNA3/SP-C-(1-194) and EGFP/SP-C-(1-194) were each expressed in CD63 (+), EEA1 (-) cytoplasmic vesicles. Expression of EGFP/SP-C-(24-194) or EGFP/SP-C-(24-58) resulted in translocation but retention in early compartments. When co-transfected with pcDNA3/SP-C-(1-194), both EGFP/SP-C-(24-194) and EGFP/SP-C-(24-58) were directed to CD63 (+) vesicles that also contained SP-C-(1-194). In contrast, trafficking of a folding mutant that forms juxtanuclear aggregates, EGFP/SP-C(C122/186G), was not corrected by cotransfection with pcDNA3/SP-C-(1-194). Chemical cross-linking studies of transfected cell lysates with bismaleimidohexane produced multimeric forms of both EGFP/SP-C-(1-194) and EGFP/SP-C-(24-58). These results indicate that sorting involves oligomeric association of proSP-C monomers mediated by the mature SP-C domain. Heteromeric assembly allows wild type proSP-C to facilitate trafficking of SP-C mutants with intact transmembrane domains but lacking targeting signals. We speculate that heterotypic oligomerization of wild type with SP-C folding mutants produces a dominant negative thus contributing to the pathology of chronic lung disease associated with patients heterozygous for mutant SP-C alleles.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11907042     DOI: 10.1074/jbc.M201537200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  High-resolution structure of a BRICHOS domain and its implications for anti-amyloid chaperone activity on lung surfactant protein C.

Authors:  Hanna Willander; Glareh Askarieh; Michael Landreh; Per Westermark; Kerstin Nordling; Henrik Keränen; Erik Hermansson; Aaron Hamvas; Lawrence M Nogee; Tomas Bergman; Alejandra Saenz; Cristina Casals; Johan Åqvistg; Hans Jörnvall; Helena Berglund; Jenny Presto; Stefan D Knight; Jan Johansson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-02       Impact factor: 11.205

2.  Disruption of N-linked glycosylation promotes proteasomal degradation of the human ATP-binding cassette transporter ABCA3.

Authors:  Michael F Beers; Ming Zhao; Yaniv Tomer; Scott J Russo; Peggy Zhang; Linda W Gonzales; Susan H Guttentag; Surafel Mulugeta
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-10-18       Impact factor: 5.464

3.  Multiple ways to die: delineation of the unfolded protein response and apoptosis induced by Surfactant Protein C BRICHOS mutants.

Authors:  Jean Ann Maguire; Surafel Mulugeta; Michael F Beers
Journal:  Int J Biochem Cell Biol       Date:  2011-10-13       Impact factor: 5.085

4.  A novel conserved targeting motif found in ABCA transporters mediates trafficking to early post-Golgi compartments.

Authors:  Michael F Beers; Arie Hawkins; Henry Shuman; Ming Zhao; Jennifer L Newitt; Jean Ann Maguire; Wenge Ding; Surafel Mulugeta
Journal:  J Lipid Res       Date:  2011-05-17       Impact factor: 5.922

5.  A non-BRICHOS SFTPC mutant (SP-CI73T) linked to interstitial lung disease promotes a late block in macroautophagy disrupting cellular proteostasis and mitophagy.

Authors:  Arie Hawkins; Susan H Guttentag; Robin Deterding; William K Funkhouser; Jennifer L Goralski; Shampa Chatterjee; Surafel Mulugeta; Michael F Beers
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-10-24       Impact factor: 5.464

6.  A nonaggregating surfactant protein C mutant is misdirected to early endosomes and disrupts phospholipid recycling.

Authors:  Michael F Beers; Arie Hawkins; Jean Ann Maguire; Adam Kotorashvili; Ming Zhao; Jennifer L Newitt; Wenge Ding; Scott Russo; Susan Guttentag; Linda Gonzales; Surafel Mulugeta
Journal:  Traffic       Date:  2011-06-28       Impact factor: 6.215

7.  A surfactant protein C precursor protein BRICHOS domain mutation causes endoplasmic reticulum stress, proteasome dysfunction, and caspase 3 activation.

Authors:  Surafel Mulugeta; Vu Nguyen; Scott J Russo; Madesh Muniswamy; Michael F Beers
Journal:  Am J Respir Cell Mol Biol       Date:  2005-03-18       Impact factor: 6.914

8.  Effect of Lung Surfactant Protein SP-C and SP-C-Promoted Membrane Fragmentation on Cholesterol Dynamics.

Authors:  Nuria Roldan; Thomas K M Nyholm; J Peter Slotte; Jesús Pérez-Gil; Begoña García-Álvarez
Journal:  Biophys J       Date:  2016-10-18       Impact factor: 4.033

9.  Endoplasmic reticulum stress induced by surfactant protein C BRICHOS mutants promotes proinflammatory signaling by epithelial cells.

Authors:  Jean Ann Maguire; Surafel Mulugeta; Michael F Beers
Journal:  Am J Respir Cell Mol Biol       Date:  2010-05-12       Impact factor: 6.914

10.  Nedd4-2-mediated ubiquitination facilitates processing of surfactant protein-C.

Authors:  Juliana J Conkright; Karen S Apsley; Emily P Martin; Ross Ridsdale; Ward R Rice; Cheng-Lun Na; Baoli Yang; Timothy E Weaver
Journal:  Am J Respir Cell Mol Biol       Date:  2009-05-07       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.